George Hyslop

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo. Abstract Background: Recent reports suggest that latrepirdine (Dimebon™, dimebolin), a retired Russian antihistamine, improves cognitive function in aged rodents and in patients with mild to moderate Alzheimer's disease(More)
  • 1